… to assess the prognostic relevance of some pre-treatment clinical … of 46 patients with stage
Ib 2 -IIb cervical cancer treated with … platinum-based neoadjuvant chemotherapy, the patients …

… It was reported that additional three to six cycles of platinum-based ACT were of benefit
for patients after NACT+RS in terms of 5-year OS and disease-free survival (DFS) (6–10). …

… factors influencing the survival and prognosis of patients with locally advanced cervical cancer
(LACC) after neoadjuvant chemotherapy (… Methods: A total of 263 patients diagnosed with …

… The cornerstone of treatment for advanced cervical cancer is platinum-based chemotherapy…
Ongoing research is exploring additional molecular markers for prognosis prediction. Liquid …

… of platinum-based consolidation chemotherapy following … stages IA1 to IIA2 cervical cancer
patients treated with radical … NLN count, and the prognostic prediction of the RLN would thus …

… The cervical tumor was treated (if there was no PA node … platinum-based chemotherapy
(cisplatin at a dose of 40 mg/m2 per week). Patients with histologic PA node metastasis after …

… A Cochrane review suggested that the addition of platinum-based CT to adjuvant RT may
improve survival in patients with early-stage (IA2-IIA) cervical cancer with risk factors.45 …

… Cervical cancer is the fourth most common cancer in females, with around 570,000 new cases
of cervical cancer diagnosed … combined with cisplatin or other platinum-based therapies. …

… poor prognostic factors of all-cause mortality in patients with cervical cancer who received
… stereotactic body RT, treated with non-platinum-based chemotherapy, with adenosquamous …

… prognostic tool in advanced cervical cancer. Prognostic Markers for Predictive Modeling …
With the adoption of platinum-based chemo-irradiation as the standard of care for locally …